These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 604192)

  • 1. Effect of carbenoxolone sodium on human gastric acid secretion.
    Baron JH
    Gut; 1977 Sep; 18(9):721-2. PubMed ID: 604192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Letter: Carbenoxolone and gastric secretion.
    Walker V; Taylor WH
    Lancet; 1975 Jun; 1(7920):1335. PubMed ID: 49532
    [No Abstract]   [Full Text] [Related]  

  • 3. Serum carbenoxolone in patients with gastric and duodenal ulcer: Absorption, efficacy and side-effects.
    Baron JH; Gribble JN; Rhodes C; Wright PA
    Gut; 1978 Apr; 19(4):330-5. PubMed ID: 648939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastric acid secretion in patients with prepyloric ulcer and with combined gastric and duodenal ulcer.
    Dahlgren S; Nordgren B
    Acta Chir Scand; 1976; 142(8):599-604. PubMed ID: 1032067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of peptic ulcer with Biogastrone (carbenoxolone)].
    Brailski Kh; Dimitrov B
    Vutr Boles; 1979; 18(5):37-44. PubMed ID: 516651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effectiveness of carbenoxolone in the treatment of gastro-duodenal ulcer patients.
    Loginov AS; Speransky MD; Speranskaya IE; Vasilyev UV; Alecseev VF
    Scand J Gastroenterol Suppl; 1980; 65():85-91. PubMed ID: 7010530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Quantitative determination of basal gastric secretion and maximal pentagastrin-induced gastric secretion in gastric and duodenal ulcers in children 3 to 14 years of age].
    Mryglodowicz A
    Pol Tyg Lek; 1976 Mar; 31(10):403-5. PubMed ID: 1264843
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of carbenoxolone on ionic fluxes across normal gastric mucosa and that associated with gastric ulcer.
    Ivey KJ; Gray C
    Aust N Z J Med; 1973 Oct; 3(5):451-6. PubMed ID: 4591118
    [No Abstract]   [Full Text] [Related]  

  • 9. Salivary secretion in duodenal ulcer disease.
    Blum AL
    Gut; 1972 Sep; 13(9):713-7. PubMed ID: 4565263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of hypothiazide on gastric secretion in peptic ulcer].
    Orlikov GA; Makena VD
    Vrach Delo; 1980 Mar; (3):26-8. PubMed ID: 7376605
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of sodium taurocholate on gastric secretion in patients with duodenal ulceration.
    Lewin MR; Pifano E; Daniel RD; Boulos PB; Clark CG
    Gut; 1983 Jan; 24(1):28-32. PubMed ID: 6848430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of intragastric neutralization on the gastric acid response to antral distension in man.
    Bergegårdh S; Knutson U; Olbe L
    Scand J Gastroenterol; 1975; 10(6):625-31. PubMed ID: 1179156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory effect of cimetidine on gastric acid secretion vagally activated by physiological means in duodenal ulcer patients.
    Schöön IM; Olbe L
    Gut; 1978 Jan; 19(1):27-31. PubMed ID: 624502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The short pentagastrin test in the investigation of gastric disease.
    Kirkpatrick JR; Lawrie JH; Forrest AP; Campbell H
    Gut; 1969 Sep; 10(9):760-2. PubMed ID: 4917340
    [No Abstract]   [Full Text] [Related]  

  • 15. Sialic acid secretion of patients with gastric and duodenal ulcers in the dose-response pentastrin test.
    Ala-Kaila K; Ahola T; Keyriläinen O; Uusitalo A
    Ann Clin Res; 1979 Jun; 11(3):107-12. PubMed ID: 496372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of carbenoxolone on electrolyte output of salivary glands during nasogastric intubation.
    Ivey KJ
    Am J Dig Dis; 1976 Dec; 21(12):1033-6. PubMed ID: 1015503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carbenoxolone: a review of its pharmacological properties and therapeutic efficacy in peptic ulcer disease.
    Pinder RM; Brogden RN; Sawyer PR; Speight TM; Spencer R; Avery GS
    Drugs; 1976; 11(4):245-307. PubMed ID: 780088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapy of peptic ulcer in the stomach and duodenum using carbenoxolone (Biogastrone and Biogastrone-Duodenal)].
    Ronský R; Fric P; Huslarová A; Malis F; Josífko M
    Cesk Gastroenterol Vyz; 1978 Mar; 32(2):98-104. PubMed ID: 350435
    [No Abstract]   [Full Text] [Related]  

  • 19. [Relationship between basal gastric secretion and postvstimulation secretion in gastric and duodenal ulcer and in the normal human population].
    Gomez JM; Quereda LA; Garcia JG; Desfilis MA; Puchalt JA; Wassel AH; Civera BF; Gomez FJ
    Rev Esp Enferm Apar Dig; 1977 Mar; 49(5):589-86. PubMed ID: 854631
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of naloxone on basal, by somatostatin inhibited stomach secretion in patients with chronic duodenal ulcer].
    Lukin M; Markiewicz K
    Gastroenterol J; 1990; 50(2):72-7. PubMed ID: 1977411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.